Relay Therapeutics, Inc.RLAY
Price (close)
$17.73
Market cap
$3.9B
P/E
—
Revenue (TTM)
$10.3M
Net income
-$286.0M
Dividend yield
—
1-year total return
304.8%
Net margin
-2763.6%
Revenue growth
23.9%
Debt / equity
—
What Relay Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $82.7M | $3.0M | $1.4M | $25.5M | $10.0M | $15.4M |
| Net income | -$52.4M | -$363.9M | -$290.5M | -$342.0M | -$337.7M | -$276.5M |
| Free cash flow | -$104.4M | -$77.9M | -$238.6M | -$304.4M | -$251.1M | -$235.9M |
More on RLAY.
- Relay Therapeutics, Inc. summary
- Relay Therapeutics, Inc. financial statements
- Relay Therapeutics, Inc. key metrics
- Relay Therapeutics, Inc. health scores and style box
- Relay Therapeutics, Inc. earnings
- Relay Therapeutics, Inc. dividends
- Relay Therapeutics, Inc. valuation
- Relay Therapeutics, Inc. ownership and insiders
- Relay Therapeutics, Inc. peers
Figures from Relay Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.